Transimmune
Pre-clinicalWe build immune cell therapies that drive a truly physiologic partnership with the immune network. By using cells primed by millions of years of evolution, our products represent a breakthrough in the use of dendritic cells to reprogram immunity.
Founded
2000
Focus
Cell & Gene Therapy
About
We build immune cell therapies that drive a truly physiologic partnership with the immune network. By using cells primed by millions of years of evolution, our products represent a breakthrough in the use of dendritic cells to reprogram immunity.
Company Info
TypePrivate
Founded2000
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile